Ma­jor dereg­u­la­tion? FDA with­draws sev­er­al rules and reg­u­la­tions re­lat­ed to med­ical prod­ucts

Al­most a year ago, Pres­i­dent Don­ald Trump told phar­ma­ceu­ti­cal ex­ec­u­tives that his ad­min­is­tra­tion would cut 75% to 80% of FDA reg­u­la­tions, “at a lev­el no one has ever seen be­fore.”

Since those com­ments last Jan­u­ary, the FDA has with­drawn the most rule­mak­ings of any De­part­ment of Health and Hu­man Ser­vices agency, though on­ly a hand­ful are re­lat­ed to med­ical prod­ucts (the oth­ers are to­bac­co re­lat­ed) and it’s un­clear how the with­draw­al of these pro­pos­als and reg­u­la­tions so far in 2017 will im­pact pa­tient safe­ty or in­dus­try bur­dens.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.